CRISPR-Cas9, an RNA-guided DNA endonuclease, is used as a tool for genome editing techniques of directed mutations in the eukaryotic genome. Avance Biosciences, Inc. has adopted an accurate and sensitive method for edited cell percentage determination using NGS amplicon sequencing of CRISPR-Cas9 transfected clones. This method can identify homozygous or heterozygous mutants and/or mixed clones.
NGS Amplicon sequencing is a highly targeted approach that enables researchers to analyze genetic variation in specific genomic regions. The sequencing of PCR products targeting the genome regions modified by the CRISPR technology allows accurate identification of gene editing profiles.
Avance Biosciences has developed and validated (in compliance with GLP and per ICH guidance) custom NGS amplicon sequencing assays to analyze the percentage of edited cells and the ratio between various indels and wild-type genes, in animal tissues or human blood collected for preclinical and clinical pharmacokinetics studies.
Digital PCR can accurately determine the ratio between edited genes and wild-type genes, especially when the size of the deletions introduced by CRISPR is too large to be accurately quantified using qPCR or amplicon sequencing.
We are dedicated to timely, high-quality service from the start of your project to the finish. Send us a note or give us a call to find out what Avance can do for you.
From the preliminary conclusion of this work, we are already pleased to thank you for your customer-oriented approach and proactive communication in the course of this study. We are happy to see the profound difference in business mindset between your organization and our previous vendor…
Project Manager, Belgium
Thank you so much for successfully completing this important project for us on time. We are very satisfied with the final report and thank you for taking the extra effort to customize the report format. We will definitely use your lab for future projects.
Program Manager, California
It has been a pleasure working with you and your team. The project was carried out to the highest standard and delivered in a timely manner. I will definitely recommend Avance Biosciences’ services to colleagues and friends.
Senior Scientist, Singapore
When you partner with Avance Biosciences, we give you undivided attention, share our experience and knowledge, and respond to your needs in a timely manner. Contact our technical staff to discuss how we can support you in your project!
Dedication to Quality
The Avance Biosciences team is committed to strict adherence to cGMP and GLP regulations enacted by the US, European, Japanese, and other international regulatory agencies.
Our team has extensive knowledge and experience working with scientists, QA/QC professionals, and project managers from over 100 pharmaceutical and biotechnology companies and organizations throughout the world.
Transparency and integrity are two of our core values. Our well-trained, friendly, and professional study directors and project managers strive to complete your projects on-time with open communication channels and to your specifications.
Avance Biosciences’ cGMP/GLP compliant genomic and microbial assays make use of the advanced technologies including real-time PCR, ddPCR, Sanger sequencing, next-gen sequencing, Southern blot, and more.